Clinical Trials on Red Blood Cell Transfusion in Norway
Total 219 results
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedPure Red-cell AplasiaUnited Kingdom, Sweden, South Africa, Brazil, Canada, Germany, Norway, Thailand
-
Wellspect HealthCareCompletedBlood Transfusion | Arthroplasty, Replacement, Hip | Blood Transfusion, AutologousAustria, Netherlands, Norway, Spain
-
Haukeland University HospitalCompletedAutologous Blood Transfusion | Physical Performance | Donor SafetyNorway
-
Haukeland University HospitalActive, not recruitingAllergy | Transfusion Reaction | Anaphylaxis | Febrile Transfusion ReactionNorway
-
Haukeland University HospitalCompleted
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedPure Red-cell AplasiaUnited Kingdom, Sweden, South Africa, Brazil, Norway, France, Thailand
-
Dartmouth-Hitchcock Medical CenterBEST research collaborativeCompletedBlood TransfusionNorway, United States, Australia, Canada, United Kingdom, Brazil
-
Haukeland University HospitalNorwegian Armed Forces Medical ServiceCompletedTrauma | Austere Environment | Blood Bank | Buddy TransfusionNorway
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen-Cilag International NVCompletedChronic Kidney Failure | Pure Red-Cell AplasiaPoland, United Kingdom, Belgium, Germany, Spain, Portugal, Australia, Switzerland, Finland, Greece, Sweden, Netherlands, Norway, Ireland, Denmark
-
St. Olavs HospitalOslo University Hospital; Norwegian University of Science and TechnologyCompletedCutaneous T-Cell Lymphoma, Unspecified | Chronic Graft Versus Host Disease in SkinNorway
-
Oslo University HospitalCompleted
-
Norwegian University of Science and TechnologyThe Research Council of Norway; Nordic Myeloma Study Group, GermanyCompleted
-
Ullevaal University HospitalCompleted
-
Oslo University HospitalRecruiting
-
Ullevaal University HospitalCompleted
-
Norwegian University of Science and TechnologyOslo University Hospital; St. Olavs HospitalCompleted
-
Oslo University HospitalTargovax ASARecruitingMultiple Myeloma | Smoldering Multiple MyelomaNorway
-
Oslo University HospitalUnknownAcute Lymphoblastic Leukemia | ThromboembolismNorway
-
Nordic Lymphoma GroupAmgenCompletedDiffuse Large B-Cell LymphomaNorway, Denmark, Finland, Sweden
-
Haukeland University HospitalNorwegian Cancer Society; The Norwegian Melanoma GroupTerminatedMetastatic Malignant Melanoma | Unresectable Malignant MelanomaNorway
-
Lund University HospitalCelgene; Janssen, LP; Nordic Lymphoma GroupCompletedRelapsed/Refractory Mantle Cell LymphomaFinland, Denmark, Sweden, Norway
-
University of AarhusNordic Lymphoma GroupCompletedPeripheral T-Cell LymphomaNorway, Finland, Denmark
-
Oslo University HospitalHelse Stavanger HF; St. Olavs Hospital; Nordic Myeloma Study GroupActive, not recruiting
-
Oslo University HospitalNordic Myeloma Study GroupActive, not recruitingMyelomaNorway, Denmark, Sweden
-
Norwegian University of Science and TechnologyOslo University Hospital; St. Olavs Hospital; Norwegian Cancer SocietyActive, not recruitingChildhood Acute Lymphoblastic Leukemia | Childhood Acute Myeloid Leukemia | Childhood Non-Hodgkin LymphomaNorway
-
Henrik GregersenNordic Myeloma Study GroupUnknownMultiple MyelomaFinland, Denmark, Sweden, Norway, Lithuania
-
Jeanette LundinRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaSweden, Norway
-
Oslo University HospitalUniversity Hospital of North Norway; Helse Stavanger HF; Haukeland University... and other collaboratorsRecruiting
-
Ida Bruun KristensenOdense Patient Data Explorative Network; Karyopharm Therapeutics IncActive, not recruitingMultiple MyelomaDenmark, Norway, Estonia
-
Lund University HospitalMundipharma Pte Ltd.; Roche Pharma AG; CelgeneCompletedMantle Cell LymphomaFinland, Denmark, Norway, Sweden
-
Nordic Myeloma Study GroupJanssen-Cilag Ltd.Unknown
-
European Myeloma NetworkSanofi; Amgen; EMN Research ItalyActive, not recruitingMultiple MyelomaCzechia, Germany, Greece, Italy, Netherlands, Norway, Spain
-
Nordic Society for Pediatric Hematology and OncologyOulu University HospitalSuspendedAcute Lymphoblastic LeukemiaFinland, Denmark, Sweden, Iceland, Norway
-
Nordic Lymphoma GroupHelsinki University Central Hospital; Aarhus University HospitalRecruitingLymphoma, Large B-Cell, DiffuseDenmark, Norway, Sweden, Finland
-
Nordic Society for Pediatric Hematology and OncologyLund University HospitalCompletedAcute Lymphoblastic Leukemia (ALL)Finland, Denmark, Iceland, Norway, Sweden
-
Nordic Lymphoma GroupActive, not recruitingRelapsed Non Hodgkin LymphomaNorway, Sweden, Finland, Denmark
-
SanofiCompletedDiffuse Large B-Cell LymphomaNorway, Austria, France
-
Rigshospitalet, DenmarkNordic Society for Pediatric Hematology and OncologyCompletedAcute Lymphoblastic LeukemiaFinland, Denmark, Norway, Sweden, Iceland
-
Genentech, Inc.RecruitingMultiple MyelomaSpain, Australia, Denmark, Norway
-
Nordic Myeloma Study GroupNordic Cancer UnionCompletedMultiple MyelomaDenmark, Norway, Sweden
-
Cancer Research UKUnknownLymphoma | Small Intestine CancerUnited Kingdom
-
University of AarhusCompletedRecurrence | Precursor Cell Lymphoblastic Leukemia-LymphomaFinland, Denmark, Iceland, Norway, Sweden
-
Rigshospitalet, DenmarkNordic Society for Pediatric Hematology and OncologyCompletedAcute Lymphoblastic LeukemiaFinland, Denmark, Iceland, Norway, Sweden
-
OnxeoCompletedMultiple MyelomaUnited States, Denmark, United Kingdom, Norway
-
SanofiRecruitingPlasma Cell Myeloma RefractoryFrance, Australia, Greece, Italy, Norway, United States, Portugal, Puerto Rico, Germany
-
Nordic Lymphoma GroupAstraZenecaActive, not recruitingMantle Cell Lymphoma | MCLFinland, Sweden, Norway, Denmark, Korea, Republic of
-
Genentech, Inc.RecruitingMultiple MyelomaAustralia, Spain, Israel, Korea, Republic of, Greece, Norway, Denmark
-
European Myeloma NetworkJanssen Research & Development, LLCActive, not recruitingMultiple MyelomaNorway, Denmark, Netherlands, Czechia, Australia, Turkey, Spain, Belgium, Switzerland, France, Greece, Italy, Poland
-
Genentech, Inc.CompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaBelgium, Australia, Denmark, Norway
-
Multiple Myeloma Research FoundationTerminated